NHS England pauses new prescriptions of cross-sex hormones for under-18s

UK Pauses Prescribing Cross-Sex Hormones to Children Following Review

Prescribing cross-sex hormones to 16 and 17-year-olds has been paused in the UK after a review by national health authorities found that evidence does not support their use. Masculinizing or feminizing hormones have been available for over a decade for young people aged 16-18 with a diagnosis of gender dysphoria who meet certain criteria, but all new referrals have been paused since March 9. NHS England said that patients in this age group who a…

NHS pause on children’s cross-sex hormones doesn’t go far enough

The NHS’s decision to pause new prescriptions of cross-sex hormones to 16- and 17-year-olds comes with an important admission. According to NHS England, an extensive review of the impact of testosterone and estrogen on young people “does not support the continued use” of such drugs. “We cannot say if they are harmful or effective,” acknowledges Professor James Palmer, National Medical Director for Specialized Services at NHS England. In other wo…

Gender-affirming hormones on NHS halted for under-18s

Gender-affirming hormone treatment for teenagers halted by NHS

The medication can cause irreversible changes, such as deepening of the voice when taking testosterone, or breast development when taking oestrogen.

NHS England pauses new prescriptions of cross-sex hormones for trans youth

NHS England has paused new prescriptions of cross-sex hormones for 16 and 17-year-old trans youth following the Cass Review.

NHS pauses hormone treatment for teenagers following evidence review

NHS England has paused new referrals for gender-affirming hormone treatment for 16 and 17-year-olds after a review following the Cass Review found insufficient evidence to support its continued use